OPKO Health

OPK NASDAQ
2.030
+0.020
+1.00%
盘前: 2.040 +0.01 +0.50% 08:05 06/25 EDT
开盘
2.020
昨收
2.010
最高
2.070
最低
2.010
成交量
341.27万
成交均量(3M)
427.10万
52周最高
6.40
52周最低
1.730
换手率
0.55%
市值
12.50亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供OPKO Health OPK股票价格,OPKO Health股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

OPKO Health, Inc. is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health), GeneDx and Laboratorio Bueno Salud. As of December 31, 2016, it had one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Biologics, hGH-CTP, Factor VII, Oxyntomodulin, active pharmaceutical ingredients, Oligonucleotide Therapeutics, NK-1 Program, Asthma and chronic obstructive pulmonary disease.
展开 >

最近浏览

名称
价格
涨跌幅